Does knee cartilage really “regenerate”? What stem cell conditioned media actually works on is not the cartilage itself but the inflammatory environment inside the joint2026.07.08

When patients are told they have knee osteoarthritis, one of the most common questions we hear is this: “If I get stem cell conditioned media injected, will my worn-out cartilage grow back to normal?” Let me answer honestly. Knee cartilage does not “regenerate to its original state” with a single injection. That, however, does not mean stem cell conditioned media joint injections have no value. What the conditioned media primarily acts on is not the cartilage itself, but the inflammatory environment inside the joint. Understanding this distinction is the starting point for avoiding both excessive expectations and unfounded disappointment about the treatment.

Key points of this article

・It has not been medically proven that worn cartilage in knee osteoarthritis can be “restored to its original state” by stem cell conditioned media injections

・What the conditioned media primarily acts on is thought to be the inflammatory environment inside the joint, including synovitis, rather than the cartilage itself

・The realistic goal is to calm the vicious cycle of pain and inflammation, and to create an environment that helps the remaining joint tissue last longer

・The range of what can be expected varies by progression grade (KL classification), and end-stage joint destruction may be better addressed by total knee replacement

・Assertive advertising expressions such as “cartilage revived in a single session” should be viewed cautiously, and expectations must be calibrated to reality

Where does the misunderstanding that “cartilage regenerates” come from?

Because of the image the word “regenerative medicine” evokes, many people interpret it as “lost tissue returns to its original state.” On social media and in clinic advertising, phrases like “cartilage revived” or “knees restored” are not uncommon.

However, adult articular cartilage (hyaline cartilage) has no blood vessels, nerves, or lymphatics, and its self-repair capacity is extremely limited. Damaged hyaline cartilage does not return to its original structure when left alone; it is either replaced by fibrocartilage or remains as a defect. No matter how much injection technology advances, this biological fact does not change easily.

The essence of knee osteoarthritis is not simply “cartilage wearing down,” but a chronic inflammatory disease of the entire joint involving cartilage, synovium, subchondral bone, ligaments, and menisci — this is the modern understanding. The simple equation of “if cartilage grows back, the disease is cured” fails to capture the reality.

What actually generates the pain in knee osteoarthritis?

It may come as a surprise, but cartilage itself contains no nerves. In other words, the “wearing down” of cartilage is not directly the cause of pain. Where, then, does knee pain come from?

The main sources include inflammation of the synovium (the membrane surrounding the joint), load stress and intraosseous pressure changes on the subchondral bone, strain on the joint capsule and ligament attachments, and secondary symptoms in surrounding muscle and tendon attachments. In particular, synovitis has been shown to be deeply involved in pain and joint effusion (the state known as “fluid in the knee”).

The synovium releases inflammatory cytokines such as IL-1β and TNF-α, along with proteolytic enzymes such as MMP-13 that degrade the cartilage matrix. These further break down cartilage, and the degradation products in turn irritate the synovium — this vicious cycle is a major driving force behind disease progression. In other words, what generates the pain is not the “amount of cartilage” but the “inflammatory environment inside the joint,” and this perspective becomes the starting point for treatment strategy.

What is stem cell conditioned media thought to be doing inside the joint?

Stem cell conditioned media is a liquid containing cytokines, growth factors, and exosomes secreted by mesenchymal stem cells (such as adipose-derived cells) into the culture medium during culture. It is known to contain reparative growth factors such as TGF-β, HGF, IGF-1, and bFGF, and cytokines with reported anti-inflammatory action.

Based on current research findings and clinical impressions, what these are thought to do inside the joint can be honestly summarized in three points. First, they work to calm inflammation of the synovium. Second, they may push the metabolic balance of chondrocytes (the seesaw between synthesis and degradation) toward the synthesis side. Third, they adjust the overall cytokine environment inside the joint from “inflammation mode” toward “repair mode” — a so-called paracrine effect.

However, this is not a phenomenon of “filling in cartilage defects and restoring their original shape.” The most medically honest framing is that what stem cell conditioned media plays a role in during a knee joint injection for knee osteoarthritis is not the regeneration of cartilage into a brand-new state, but rather regulating the intra-articular environment to break the vicious cycle of pain and to help the remaining tissue last longer.

Realistic expectations by progression grade of knee osteoarthritis

The progression of knee deformity is classified into grades I to IV using the Kellgren-Lawrence (KL) classification based on X-rays. The range that can be expected from joint injections clearly changes by grade.

In KL I to II (early to mild), the shape of cartilage and bone has not yet significantly collapsed. At this stage, calming pain and synovitis can make it easier to resume daily activities and exercise. This is also a stage where combination with exercise therapy and weight control is easy, and where the significance of considering a conditioned media joint injection is relatively clear.

In KL III (moderate), joint space narrowing, osteophytes, and subchondral bone changes become evident. While symptom relief can be expected, the advanced deformity itself will not return to normal. It is necessary to position “less pain and easier movement” as a realistic goal.

In KL IV (end-stage), cartilage is almost lost and the joint space has disappeared. Once at this level, the range that can be expected from a stem cell conditioned media joint injection is limited. Total knee replacement — a surgical approach — is often the stage where quality of life can be improved substantially, and consulting an orthopedic surgeon may be more appropriate than continuing to persist with injections.

How to face the advertising claim that “cartilage regenerates”

Medical advertising guidelines restrict assertive or misleading expressions of superiority. In reality, however, we sometimes see phrases such as “cartilage regenerates with stem cell conditioned media” or “a single session rejuvenates the knee.” As explained above, there is currently no established evidence that adult hyaline cartilage “regenerates” to its original state through injection.

When encountering such assertive advertising, we recommend a perspective that verifies: (i) which academic society has approved or recommended the treatment, (ii) what indicator is used to evaluate efficacy (pain, range of motion, or imaging of cartilage), and (iii) whether long-term outcome data exist. For information on joint diseases, it is also useful to refer to public information from bodies such as the Japanese Orthopaedic Association.

What to sort out before considering joint injections for knee osteoarthritis

A stem cell conditioned media knee joint injection is not a magic treatment that completes its effect on its own. It only becomes meaningful when placed on top of a foundation of conservative therapy — exercise therapy, weight control, review of daily movements, and orthotic devices (supporters, insoles, and a cane if needed).

In the clinic, we check together: (i) staging by X-ray and, if needed, MRI, (ii) the degree of synovitis and joint effusion, (iii) factors outside the knee (alignment of the hip and ankle, trunk muscle function), and (iv) combinations with other conservative therapies. On top of these, we discuss with the patient whether a conditioned media joint injection is realistically a candidate option at that stage.

If you would like to know more about the treatment, please also refer to this page for more on stem cell conditioned media joint injections.

Frequently Asked Questions

Q. If I get a knee joint injection for knee osteoarthritis, will my worn-out cartilage grow back to normal?

At present, it has not been medically proven that adult hyaline cartilage regenerates to its original state by injection. What the conditioned media is involved in is regulation of the inflammatory environment inside the joint and the metabolic balance of chondrocytes, and the honest explanation is to treat this as separate from “a treatment that fills in cartilage defects.”

Q. How soon can I feel the effect, and how long does it last?

Changes in pain and swelling are generally evaluated over a span of several weeks to several months after injection. Duration varies from person to person and is greatly affected by progression, body weight, activity level, and the exercise therapy used in combination. Because this is not a treatment that can guarantee long-term efficacy with a single session, we make decisions on continuation or revision while following the course.

Q. What is the difference between hyaluronic acid injections and stem cell conditioned media joint injections?

Hyaluronic acid is a physical approach that supplements the viscoelasticity and lubrication of joint fluid, and has long been used even in insurance-covered care. Stem cell conditioned media, on the other hand, is a biological approach that aims to act on the inflammatory environment inside the joint and the metabolic environment of the cells. Because the objectives differ, the question is not “which is superior” — we consider their respective roles or complementary use while watching the disease stage and response.

Q. I have been told my joint is end-stage. Is there still meaning in receiving conditioned media injections?

In cases with progression corresponding to KL IV, resolving the fundamental problem by injection alone becomes difficult. The idea of “persisting with injections to postpone surgery” is not necessarily the best choice for the patient. We recommend first laying out options including total knee replacement with an orthopedic surgeon and making the decision from there.

Q. Who is stem cell conditioned media joint injection not suitable for?

Those with active intra-articular infection, poorly controlled systemic disease, or severe functional impairment due to advanced joint destruction fall outside the indication for joint injection, or require careful judgment. Pregnant and breastfeeding women are also, in principle, not candidates. We consider suitability after first sorting out the current diagnosis and overall health status.

──────────────

Supervised by: Shin Moriwaki, MD (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG certificate holder

──────────────

📍AVAN TOKYO Ginza Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries via DM / LINE / Website / Phone are welcome.